You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康希諾生物(06185.HK)終止與輝瑞(PFE.US)腦膜炎球菌結合疫苗獨家推廣授權協議
康希諾生物(06185.HK)公布,有關公司與輝瑞(PFE.US)簽署的推廣服務協議、授權輝瑞在中國獨家推廣其A、C、Y和W135群腦膜炎球菌結合疫苗(MCV4,產品名稱為曼海欣),公司與輝瑞於日前(6月4日)簽署終止協議,各方同意即日起終止該協議及獨家推廣授權。公司與輝瑞將協力就終止該協議項下合作交接未盡事項。 公司表示,已建立體系完備的商業營運中心,藉助商業化團隊推廣MCV4可以幫助公司規劃及執行國內外市場策略及營銷活動,認為終止該協議的決定不會對集團的業務、經營或財務狀況產生重大不利影響。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account